Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2004 | 06-2003 | 06-2002 | 06-2001 | 06-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,201 | 39,371 | 26,393 | 21,268 | 17,356 |
| Marketable Securities | 42,534 | 79,392 | 70,671 | 75,804 | 42,468 |
| Receivables | 21,099 | 19,179 | 21,259 | 18,322 | 18,891 |
| Inventories | 7,457 | 6,332 | 6,077 | 5,438 | 4,652 |
| Income taxes - deferred | 4,820 | 4,237 | 3,762 | 2,720 | 2,440 |
| TOTAL | $128,065 | $149,515 | $129,078 | $124,192 | $86,301 |
| Non-Current Assets | |||||
| PPE Net | 80,504 | 81,166 | 70,313 | 49,194 | 46,266 |
| Investments And Advances | 91,342 | 4,398 | 0 | 0 | 0 |
| Intangibles | 15,359 | 16,958 | 18,897 | 27,446 | 36,336 |
| Other Non-Current Assets | 10,190 | 11,240 | 19,960 | 14,693 | 11,507 |
| TOTAL | $197,395 | $113,762 | $109,169 | $91,334 | $94,108 |
| Total Assets | $325,460 | $263,277 | $238,247 | $215,525 | $180,410 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,281 | 1,234 | 950 | 885 | 824 |
| Accounts payable and accrued liabilities | 3,847 | 4,821 | 10,806 | 9,632 | 8,738 |
| Accrued Expenses | 3,416 | 1,781 | 2,874 | 2,303 | 2,999 |
| TOTAL | $13,459 | $10,808 | $14,630 | $15,892 | $12,561 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,576 | 15,852 | 17,101 | 18,050 | 18,935 |
| aiOther Non-Current Liabilities | 0 | 0 | 0 | 3,923 | 7,768 |
| TOTAL | $14,576 | $15,852 | $17,101 | $21,973 | $26,703 |
| Total Liabilities | $28,035 | $26,660 | $31,730 | $37,865 | $39,264 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 164,676 | 164,110 | 165,308 | 165,775 | N/A |
| Common Shares | 412 | 409 | 416 | 414 | 414 |
| Retained earnings | 222,728 | 169,809 | 147,369 | 121,210 | 88,336 |
| Other shareholders' equity | 5,325 | 3,120 | 148 | -1,346 | -462 |
| TOTAL | $297,425 | $236,617 | $206,517 | $177,660 | $141,145 |
| Total Liabilities And Equity | $325,460 | $263,277 | $238,247 | $215,525 | $180,410 |